Financiación liderada por los inversores existentes Fountain Healthcare Partners y Panakès Partners. Los fondos se utilizarán para acelerar la comercialización de Lenire en EE.UU. y Europa. DUBLÍN, 11 de marzo de 2025 /PRNewswire/ — Neuromod Devices Ltd (Neuromod), empresa irlandesa de…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.